We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.01B
AUM Growth
+$51.4M
Cap. Flow
+$4.67M
Cap. Flow %
0.46%
Top 10 Hldgs %
30.68%
Holding
182
New
9
Increased
47
Reduced
78
Closed
1

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$2.01M
2
ALC icon
Alcon
ALC
+$1.1M
3
CTSH icon
Cognizant
CTSH
+$1.02M
4
ABB
ABB Ltd
ABB
+$986K
5
USB icon
US Bancorp
USB
+$917K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.21M
2
NVS icon
Novartis
NVS
+$1.19M
3
MSFT icon
Microsoft
MSFT
+$815K
4
DOX icon
Amdocs
DOX
+$732K
5
RTX icon
RTX Corp
RTX
+$648K

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Healthcare 16.99%
3 Financials 12.14%
4 Consumer Staples 10.6%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVO
151
Novo Nordisk
NVO
$227B
$315K 0.03%
12,334
– –
EV
152
DELISTED
Eaton Vance Corp.
EV
$305K 0.03%
7,082
– –
D icon
153
Dominion Energy
D
$62.2B
$304K 0.03%
3,931
-395
-9% -$30.1K
EPD icon
154
Enterprise Products Partners
EPD
$83.6B
$303K 0.03%
10,496
– –
VO icon
155
Vanguard Mid-Cap ETF
VO
$106B
$287K 0.03%
6,860
+320
+5% +$13.1K
GPC icon
156
Genuine Parts
GPC
$17.8B
$267K 0.03%
2,577
– –
VB icon
157
Vanguard Small-Cap ETF
VB
$79B
$263K 0.03%
1,676
+115
+7% +$17.8K
WST icon
158
West Pharmaceutical
WST
$23.6B
$261K 0.03%
2,088
– –
CPB icon
159
Campbell Soup
CPB
$6.83B
$255K 0.03%
6,367
– –
HSY icon
160
Hershey
HSY
$37.6B
$250K 0.02%
1,862
– –
YUM icon
161
Yum! Brands
YUM
$42B
$250K 0.02%
2,259
– –
CACC icon
162
Credit Acceptance
CACC
$5.95B
$248K 0.02%
512
– –
AME icon
163
Ametek
AME
$53.9B
$238K 0.02%
2,624
-1,000
-28% -$85.7K
DE icon
164
Deere & Co
DE
$166B
$238K 0.02%
1,439
– –
SPY icon
165
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$234K 0.02%
800
– –
BKNG icon
166
Booking.com
BKNG
$156B
$232K 0.02%
3,100
– –
VWO icon
167
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$230K 0.02%
5,415
+25
+0.5% +$1.05K
BIIB icon
168
Biogen
BIIB
$31.2B
$225K 0.02%
961
-66
-6% -$15.2K
APC
169
DELISTED
Anadarko Petroleum
APC
$221K 0.02%
+3,139
New +$210K
IOSP icon
170
Innospec
IOSP
$2.11B
$219K 0.02%
2,400
– –
ORLY icon
171
O'Reilly Automotive
ORLY
$75.4B
$218K 0.02%
8,850
– –
NTRS icon
172
Northern Trust
NTRS
$22B
$215K 0.02%
2,387
– –
DVY icon
173
iShares Select Dividend ETF
DVY
$24B
$214K 0.02%
2,153
– –
BF.A icon
174
Brown-Forman Class A
BF.A
$13.7B
$210K 0.02%
+3,814
New +$200K
IEX icon
175
IDEX
IEX
$17.1B
$209K 0.02%
+1,212
New +$190K
4 5 6
7
8

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q2 2019 Portfolio in Review

As of Q2 2019, Grandfield & Dodd held 182 positions worth $1.01B, up 5.4% from $960M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q2 2019 filing shows 9 new, 47 increased, 78 reduced and 1 closed positions. Its largest new stake was Alcon: 18,816 shares worth $1.17M. The largest sale was Merck, an estimated $1.21M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q2 2019 buy was Alcon: 18,816 shares worth $1.17M.
  • Grandfield & Dodd added most to Blackbaud in Q2 2019, an estimated $2.01M increase.
  • Grandfield & Dodd's biggest Q2 2019 reduction was Merck, cutting an estimated $1.21M.
  • Grandfield & Dodd fully exited Vanguard FTSE Europe ETF in Q2 2019, selling an estimated $218K.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.01B portfolio in Q2 2019.
  • Grandfield & Dodd opened 9 new positions and closed 1 in Q2 2019.
  • Grandfield & Dodd's portfolio value rose 5.4% quarter-over-quarter to $1.01B.

Based on Grandfield & Dodd's 13F filing for Q2 2019, filed 29 Jul 2019.